GPP
GPP: there is more than you see
Learn about Generalized Pustular Psoriasis and how it affects people living with it
Search
35 Result(s)
GPP
The GPP Forum
The generalized pustular psoriasis (GPP) Forum - a multistakeholder event collaborating for a new vision for people living with GPP
GPP
Implementing the generalized pustular psoriasis (GPP) Charter
Read more about the projects are implementing the generalized pustular psoriasis (GPP) Charter
GPP
The GPP Forum Report
The generalized pustular psoriasis (GPP) Forum Report summarizes and highlights the important moments form the multistakeholder GPP Forum.
GPP
GPP Forum Article - Frida Dunger Johnsson, Executive Director, IFPA
Frida Dunger Johnsson, Executive Director of IFPA and panelist at the generalized pustular psoriasis (GPP) Forum, reflects on a momentous day for the GPP community.
GPP
The GPP Charter
The GPP Charter defines a collaborative approach to identifying common goals for the GPP community
GPP
The Goals to Improve Living with GPP
An article that describes the current goals to improve the lives of those living with generalized pustular psoriasis
GPP
The generalized pustular psoriasis (GPP) Forum 2023
An executive summary of the activities and key takeaways from the GPP Forum 2023
GPP
Generalized pustular psoriasis (GPP): a rare, chronic, systemic disease
A rare, chronic, systemic autoinflammatory disease that can be life-threatening if left untreated.
GPP
The Unwearable Collection™: Fashion Inspired by GPP
An introduction to The Unwearable Collection™: fashion inspired by the experiences of living with GPP, designed by Bart Hess
GPP
Living with GPP
Ray and Christine share their experiences of living with the rare skin condition, generalized pustular psoriasis (GPP).
GPP
The Unwearable Collection™
Welcome to The Unwearable Collection™, a fashion line based on the experiences of patients living with generalized pustular psoriasis, designed by Bart Hess
December 15, 2021
U.S. FDA grants priority review for spesolimab in GPP
March 28, 2022
New spesolimab data show significant improvement in GPP flares
GPP
EADV 2021: New frontiers in GPP
Dr. Emmanuelle Clerisme-Beaty (former Associate Head of Medicine - Inflammation, Boehringer Ingelheim) reflects on developments for GPP at the EADV congress, 2021
GPP
Spotlight on Generalized Pustular Psoriasis
Emmanuelle Clerisme-Beaty, former Head of Clinical Development and Medical Affairs, Dermatology, answers some frequently asked questions about GPP.
GPP
Bridging the Gap in Generalized Pustular Psoriasis
Emmanuelle Clerisme-Beaty, former Head of Clinical Development and Medical Affairs, Dermatology, discusses insights gathered from GPP patients.
GPP
Shining a Light on Generalized Pustular Psoriasis
On World Psoriasis Day, Professor Barker talks about increasing awareness of generalized pustular psoriasis in the dermatology community
Article
Unmet needs in Generalized Pustular Psoriasis (GPP)
Learn more about the unmet needs of people living with GPP and how multi-level support can be implemented to improve the lives patients.
Article
Live well with Generalized Pustular Psoriasis
Learn about why it is important to increase awareness of Generalized Pustular Psoriasis (GPP) and tips that people living with GPP have shared to live well with the disease.
January 30, 2023
Spesolimab meets key endpoint for GPP flare prevention
October 14, 2022
CHMP recommends conditional approval for first GPP treatment
July 04, 2023
Spesolimab prevents GPP flares
GPP
Generalized pustular psoriasis: The value of collaboration
Dr Emmanuelle Clerisme-Beaty, Boehringer Ingelheim’s Therapeutic Area Inflammation Head of Medicine, in conversation with Dr Bruce Strober MD, PhD
March 07, 2019